Measurement of beta-cell function is an important marker of progression to diabetes in individuals at risk for the disease. Although the peak incidence for the disease occurs before 17 years of age, normal values for insulin secretion were not available in this age group. We performed a simplified intravenous glucose tolerance test in 167 normal children, and in 98 islet cell antibody (ICA)-negative and 12 ICA-positive siblings of diabetic patients. Their age range was 1-16 yr. The first phase of insulin secretion, evaluated as the sum of plasma insulin concentrations at 1 and 3 min, increased with age and was significantly lower in ICA-negative siblings (86 +/- 6 microU/ml, P < 0.002) than in normal controls (115 +/- 6 microU/ml). This difference was not apparent before 8 yr of age. None of the ICA-negative siblings developed diabetes after an average of 4.5 yr. ICA-positive siblings at first study had a first phase insulin response similar to that of ICA negative siblings, but significantly lower than that of the normal controls (74 +/- 13 microU/ml, P < 0.02). The reason for the decreased insulin secretion in ICA-negative siblings is unknown, but could involve a defect in the growth of beta-cell mass or insulin secretion that could be part of the multifactorial pathogenesis of type 1 diabetes.
J C Carel, C Boitard, P F Bougnères
Title and authors | Publication | Year |
---|---|---|
Glucose-induced insulin secretion in isolated human islets: Does it truly reflect β-cell function in vivo?
JC Henquin |
Molecular Metabolism | 2021 |
The role of beta-cell dysfunction in early type 1 diabetes
EK Sims, RG Mirmira, C Evans-Molina |
Current opinion in endocrinology, diabetes, and obesity | 2020 |
Cause or effect? A review of clinical data demonstrating beta cell dysfunction prior to the clinical onset of type 1 diabetes
EK Sims, LA DiMeglio |
Molecular Metabolism | 2019 |
β-Cell Dysfunction Exists More than Five Years Before Type 1 Diabetes Diagnosis
Carmela Evans-Molina, Emily Sims, Linda DiMegio, Heba Ismail, Andrea Steck, Jerry P Palmer, Jeffrey Krischer, Susan Geyer, Ping Xu, Jay Sosenko |
JCI Insight | 2018 |
Dynamics and Regulation of Insulin Secretion in Pancreatic Islets from Normal Young Children
JC Henquin, M Nenquin, R Kulkarni |
PloS one | 2016 |
Reduced β-cell function in early preclinical type 1 diabetes
MK Koskinen, O Helminen, J Matomäki, S Aspholm, J Mykkänen, M Mäkinen, V Simell, M Vähä-Mäkilä, T Simell, J Ilonen, M Knip, R Veijola, J Toppari, O Simell |
European Journal of Endocrinology | 2015 |
Haploinsufficiency of Dmxl2, Encoding a Synaptic Protein, Causes Infertility Associated with a Loss of GnRH Neurons in Mouse
B Tata, L Huijbregts, S Jacquier, Z Csaba, E Genin, V Meyer, S Leka, J Dupont, P Charles, D Chevenne, JC Carel, J Léger, N Roux, S O'Rahilly |
PLoS Biology | 2014 |
A Single-Nucleotide Polymorphism in the p110 β Gene Promoter Is Associated with Partial Protection from Insulin Resistance in Severely Obese Adolescents
CL Stunff, A Dechartres, EM Giudice, P Froguel, P Bougnères |
The Journal of clinical endocrinology and metabolism | 2008 |
Association analysis indicates that a variant GATA-binding site in the PIK3CB promoter is a Cis-acting expression quantitative trait locus for this gene and attenuates insulin resistance in obese children
CL Stunff, A Dechartres, V Mariot, C Lotton, C Trainor, EM Giudice, D Meyre, I Bieche, I Laurendeau, P Froguel, D Zelenika, D Fallin, M Lathrop, PH Roméo, P Bougnères |
Diabetes | 2007 |
Índice HOMA y QUICKI, insulina y péptido C en niños sanos. Puntos de corte de riesgo cardiovascular
BG Cuartero, CG Lacalle, CJ Lobo, AG Vergaz, CC Rey, MJ Villar, ED Martínez |
Anales de Pediatría | 2007 |
IRS1, KCNJ11, PPARgamma2 and HNF-1alpha: do amino acid polymorphisms in these candidate genes support a shared aetiology between type 1 and type 2 diabetes?
A Johansen, DP Jensen, R Bergholdt, HB Mortensen, F Pociot, J Nerup, T Hansen, O Pedersen |
Diabetes, Obesity and Metabolism | 2006 |
Environmental factors related to the induction of beta-cell autoantibodies in 1-yr-old healthy children
J Wahlberg, J Fredriksson, E Nikolic, O Vaarala, J Ludvigsson |
Pediatric Diabetes | 2005 |
Emerging therapeutic strategies in autoimmune diabetes: aetiology, prediction, prevention and cure
H Iwahashi, T Hanafusa, A Imagawa, K Tomita, M Moriwaki, K Yamamoto, M Waguri, K Yamagata, N Itoh, I Yoshiuchi, T Nanmo, H Nakajima, J Miyagawa, M Namba, Y Matsuzawa |
Expert Opinion on Therapeutic Targets | 1999 |
Molecular and Cellular Pediatric Endocrinology
S Handwerger |
1999 | |
Insulin Secretion and Sensitivity in Children on Cyclic Total Parenteral Nutrition
A Lienhardt, B Rakotoambinina, V Colomb, S Souissi, E Sadoun, O Goulet, JJ Robert, C Ricour |
JPEN. Journal of parenteral and enteral nutrition | 1998 |
Prevention of Type I Diabetes and Recurrent β-Cell Destruction of Transplanted Islets*
RH Slover, GS Eisenbarth |
Endocrine reviews | 1997 |
Strategies for preventing type I diabetes mellitus
CF Verge, GS Eisenbarth |
The Western journal of medicine | 1996 |
Normal values of first-phase insulin response to intravenous glucose in healthy Italian children and adolescents
R Lorini |
Diabetologia | 1996 |